{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:39:42Z","timestamp":1788565182690,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T00:00:00Z","timestamp":1533340800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["91-01-01-5545"],"award-info":[{"award-number":["91-01-01-5545"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007432","name":"Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["ICR-100-502"],"award-info":[{"award-number":["ICR-100-502"]}],"id":[{"id":"10.13039\/501100007432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12020-018-1663-8","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T00:54:57Z","timestamp":1533344097000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between CTLA-4\u2009+\u200949A\u2009>\u2009G and \u2013\u2009318C\u2009>\u2009T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm"],"prefix":"10.1007","volume":"62","author":[{"given":"Shabnam","family":"Abtahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Izadi Jahromi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Dabbaghmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-3375","authenticated-orcid":false,"given":"Abbas","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,4]]},"reference":[{"key":"1663_CR1","unstructured":"Cancer Stat Facts: Thyroid Cancer; retrieved from \n                    https:\/\/seer.cancer.gov\/statfacts\/html\/thyro.html\n                    \n                  . Accessed 7 Feb 2018"},{"issue":"13","key":"1663_CR2","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"H. Lim, S.S. Devesa, J.A. Sosa, D. Check, C.M. Kitahara, Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317(13), 1338\u20131348 (2017). \n                    https:\/\/doi.org\/10.1001\/jama.2017.2719","journal-title":"JAMA"},{"issue":"6","key":"1663_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.beem.2008.09.017","volume":"22","author":"JA Fagin","year":"2008","unstructured":"J.A. Fagin, N. Mitsiades, Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract. Res. Clin. Endocrinol. Metab. 22(6), 955\u2013969 (2008). \n                    https:\/\/doi.org\/10.1016\/j.beem.2008.09.017","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"1663_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"D.M. Pardoll, The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12(4), 252\u2013264 (2012). \n                    https:\/\/doi.org\/10.1038\/nrc3239","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"1663_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1634\/theoncologist.2015-0282","volume":"21","author":"JL Messerschmidt","year":"2016","unstructured":"J.L. Messerschmidt, G.C. Prendergast, G.L. Messerschmidt, How cancers escape immune destruction and mechanisms of action for the new significantly active immune therapies: Helping nonimmunologists decipher recent advances. Oncologist 21(2), 233\u2013243 (2016). \n                    https:\/\/doi.org\/10.1634\/theoncologist.2015-0282","journal-title":"Oncologist"},{"issue":"12","key":"1663_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nri3108","volume":"11","author":"LSK Walker","year":"2011","unstructured":"L.S.K. Walker, D.M. Sansom, The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat. Rev. Immunol. 11(12), 852\u2013863 (2011). \n                    https:\/\/doi.org\/10.1038\/nri3108","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"1663_CR7","first-page":"127","volume":"8","author":"A Ghaderi","year":"2011","unstructured":"A. Ghaderi, CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iran. J. Immunol. 8(3), 127\u2013149 (2011).","journal-title":"Iran. J. Immunol."},{"key":"1663_CR8","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.1111\/j.1365-2567.2009.03083.x","volume":"128","author":"L Karabon","year":"2009","unstructured":"L. Karabon, A. Kosmaczewska, M. Bilinska, E. Pawlak, L. Ciszak, A. Jedynak, A. Jonkisz, L. Noga, A. Pokryszko-Dragan, M. Koszewicz, I. Frydecka, The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease. Immunology 128, e787\u2013796 (2009). \n                    https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03083.x","journal-title":"Immunology"},{"issue":"3","key":"1663_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/sj.gene.6363752","volume":"2","author":"A Ligers","year":"2001","unstructured":"A. Ligers, N. Teleshova, T. Masterman, W.X. Huang, J. Hillert, CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2(3), 145\u2013152 (2001). \n                    https:\/\/doi.org\/10.1038\/sj.gene.6363752","journal-title":"Genes Immun."},{"key":"1663_CR10","unstructured":"Retrieved from \n                    https:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP\/snp_ref.cgi?geneId=1493\n                    \n                  . Accessed 7 Feb 2018"},{"key":"1663_CR11","unstructured":"Retrieved from \n                    https:\/\/www.omim.org\/search\/?index=geneMap&start=1&search=ctla4&limit=10\n                    \n                  . Accessed 7 Feb 2018"},{"issue":"3","key":"1663_CR12","first-page":"229","volume":"29","author":"I Kimkong","year":"2011","unstructured":"I. Kimkong, J. Nakkuntod, S. Sae-Ngow, T. Snabboon, Y. Avihingsanon, N. Hirankarn, Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves\u2019 disease in Thai population. Asian Pac. J. Allergy Immunol. 29(3), 229\u2013235 (2011)","journal-title":"Asian Pac. J. Allergy Immunol."},{"issue":"3","key":"1663_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5114\/aoms.2012.28593","volume":"8","author":"D Pastuszak-Lewandoska","year":"2012","unstructured":"D. Pastuszak-Lewandoska, E. Sewerynek, D. Domanska, A. Gladys, R. Skrzypczak, E. Brzezianska, CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves\u2019 disease and Hashimoto\u2019s thyroiditis). Arch. Med. Sci. 8(3), 415\u2013421 (2012). \n                    https:\/\/doi.org\/10.5114\/aoms.2012.28593","journal-title":"Arch. Med. Sci."},{"issue":"4","key":"1663_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.gene.6363869","volume":"3","author":"XB Wang","year":"2002","unstructured":"X.B. Wang, X. Zhao, R. Giscombe, A.K. Lefvert, A. CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun. 3(4), 233\u2013234 (2002). \n                    https:\/\/doi.org\/10.1038\/sj.gene.6363869","journal-title":"Genes Immun."},{"issue":"1","key":"1663_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/br.2016.683","volume":"5","author":"TM Li","year":"2016","unstructured":"T.M. Li, C.D. Wang, Z.J. Ren, Y. Ji, C. Xu, B. Xiao, M. Liu, Association between the cytotoxic T-lymphocyte antigen 4 -318C\/T polymorphism and malignant tumor risk. Biomed. Rep. 5(1), 93\u2013100 (2016). \n                    https:\/\/doi.org\/10.3892\/br.2016.683","journal-title":"Biomed. Rep."},{"key":"1663_CR16","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s13277-013-1221-1","volume":"35","author":"HB Xu","year":"2014","unstructured":"H.B. Xu, H. Yang, T. Liu, H. Chen, Association of CTLA4 gene polymorphism (rs5742909) with cervical cancer: a meta-analysis. Tumour Biol. 35, 1605\u20131608 (2014). \n                    https:\/\/doi.org\/10.1007\/s13277-013-1221-1","journal-title":"Tumour Biol."},{"key":"1663_CR17","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2815","volume":"5","author":"Z Dai","year":"2017","unstructured":"Z. Dai, T. Tian, M. Wang, X. Liu, S. Lin, P. Yang, K. Liu, Y. Zheng, P. Xu, M. Liu, X. Yang, Z. Dai, CTLA-4 polymorphisms associate with breast cancer susceptibility in Asians: a meta-analysis. PeerJ 5, e2815 2017). https:\/\/doi.org\/10.7717\/peerj.2815","journal-title":"PeerJ"},{"issue":"4","key":"1663_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1089\/gtmb.2016.0335","volume":"21","author":"K Wang","year":"2017","unstructured":"K. Wang, Q. Zhu, Y. Lu, H. Lu, F. Zhang, X. Wang, Y. Fan, CTLA-4\u2009+\u200949 G\/A polymorphism confers autoimmune disease risk: An updated meta-analysis. Genet. Test. Mol. Biomark. 21(4), 222\u2013227 (2017). \n                    https:\/\/doi.org\/10.1089\/gtmb.2016.0335","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"5","key":"1663_CR19","first-page":"6835","volume":"8","author":"L Wang","year":"2015","unstructured":"L. Wang, Z.W. Jiang, H. Qiu, W.F. Tang, T.H. Duan, L.X. Wang, Associations between CTLA-4\u2009+\u200949 A\/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies. Int. J. Clin. Exp. Med. 8(5), 6835\u2013U3261 (2015)","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"2","key":"1663_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"M.B. Amin, F.L. Greene, S.B. Edge, C.C. Compton, J.E. Gershenwald, R.K. Brookland, L. Meyer, D.M. Gress, D.R. Byrd, D.P. Winchester, The eighth edition AJCC cancer staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J. Clin. 67(2), 93\u201399 (2017). \n                    https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA Cancer J. Clin."},{"issue":"20","key":"1663_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical, A.","year":"2013","unstructured":"World Medical, A., World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20), 2191\u20132194 (2013). \n                    https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"1663_CR22","unstructured":"CTLA4 cytotoxic T-lymphocyte associated protein 4[Homo sapiens(human)], retrieved from \n                    https:\/\/www.ncbi.nlm.nih.gov\/gene\/1493\n                    \n                  . Accessed 7 Feb 2018"},{"key":"1663_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/117693430500100003","volume":"1","author":"Laval Excoffier","year":"2005","unstructured":"Laval Excoffier, L.G. Schneider, S. Arlequin, ver. 3.0: An integrated software package for population genetics data analysis. Evol. Bioinform. Online 1, 47\u201350 (2005)","journal-title":"Evol. Bioinform. Online"},{"issue":"8","key":"1663_CR24","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1210\/jc.2007-0147","volume":"92","author":"FK Kavvoura","year":"2007","unstructured":"F.K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D.A. Chistiakov, I. Frydecka, A. Ghaderi, S.C. Gough, Y. Hiromatsu, R. Ploski, P.W. Wang, Y. Ban, T. Bednarczuk, E.I. Chistiakova, M. Chojm, J.M. Heward, H. Hiratani, S.H. Juo, L. Karabon, S. Katayama, S. Kurihara, R.T. Liu, I. Miyake, G.H. Omrani, E. Pawlak, M. Taniyama, T. Tozaki, J.P. Ioannidis, Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J. Clin. Endocrinol. Metab. 92(8), 3162\u20133170 (2007). \n                    https:\/\/doi.org\/10.1210\/jc.2007-0147","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1663_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2017.00053","volume":"7","author":"C Resende de Paiva","year":"2017","unstructured":"C. Resende de Paiva, C. Gronhoj, U. Feldt-Rasmussen, C. von Buchwald, Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients. Front. Oncol. 7, 53 (2017). \n                    https:\/\/doi.org\/10.3389\/fonc.2017.00053","journal-title":"Front. Oncol."},{"key":"1663_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154394","volume":"11","author":"WH Ting","year":"2016","unstructured":"W.H. Ting, M.N. Chien, F.S. Lo, C.H. Wang, C.Y. Huang, C.L. Lin, W.S. Lin, T.Y. Chang, H.W. Yang, W.F. Chen, Y.P. Lien, B.W. Cheng, C.H. Lin, C.C. Chen, Y.L. Wu, C.M. Hung, H.J. Li, C.I. Chan, Y.J. Lee, Association of cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene polymorphisms with autoimmune thyroid disease in children and adults: Case-control study. PLoS ONE. 11, e0154394 2016). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0154394","journal-title":"PLoS ONE."},{"issue":"1","key":"1663_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12020-016-1096-1","volume":"55","author":"E Pawlak-Adamska","year":"2017","unstructured":"E. Pawlak-Adamska, I. Frydecka, M. Bolanowski, A. Tomkiewicz, A. Jonkisz, L. Karabon, A. Partyka, O. Nowak, M. Szalinski, J. Daroszewski, CD28\/CTLA-4\/ICOS haplotypes confers susceptibility to Graves\u2019 disease and modulates clinical phenotype of disease. Endocrine 55(1), 186\u2013199 (2017). \n                    https:\/\/doi.org\/10.1007\/s12020-016-1096-1","journal-title":"Endocrine"},{"issue":"12","key":"1663_CR28","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2217\/fon-2016-0399","volume":"13","author":"DF Chang","year":"2017","unstructured":"D.F. Chang, X.H. Chen, J. Huang, Y.M. Sun, D.Y. Zhu, Z.Q. Xu, CTLA-4 gene polymorphisms associate with efficacy of postoperative radioiodine-131 for differentiated thyroid carcinoma. Future Oncol. 13(12), 1057\u20131068 (2017). \n                    https:\/\/doi.org\/10.2217\/fon-2016-0399","journal-title":"Future Oncol."},{"issue":"1","key":"1663_CR29","first-page":"650","volume":"8","author":"L Wang","year":"2015","unstructured":"L. Wang, F. Jing, D. Su, T. Zhang, B. Yang, S. Jiao, Y. Hu, L. Bai, Association between CTLA-4rs231775 polymorphism and risk of colorectal cancer: a meta analysis. Int. J. Clin. Exp. Med. 8(1), 650\u2013657 (2015)","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"1663_CR30","first-page":"3752","volume":"8","author":"L He","year":"2015","unstructured":"L. He, T. Deng, H.S. Luo, Association between cytotoxic T-lymphocyte antigen-4\u2009+\u200949A\/G polymorphism and colorectal cancer risk: a meta-analysis. Int. J. Clin. Exp. Med. 8(3), 3752\u20133760 (2015)","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"16","key":"1663_CR31","doi-asserted-by":"publisher","first-page":"26679","DOI":"10.18632\/oncotarget.15794","volume":"8","author":"H Chen","year":"2017","unstructured":"H. Chen, X. Qi, X. Bai, P. Qiu, B. Chen, Role of CD152 genetic polymorphisms in the susceptibility to breast cancer. Oncotarget 8(16), 26679\u201326686 (2017). \n                    https:\/\/doi.org\/10.18632\/oncotarget.15794","journal-title":"Oncotarget"},{"issue":"11","key":"1663_CR32","first-page":"15118","volume":"8","author":"Z Liu","year":"2015","unstructured":"Z. Liu, Z. Song, J. Sun, F. Sun, C. Li, J. Sun, L. Xu, Association between CTLA-4rs231775 polymorphism and hepatocellular carcinoma susceptibility. Int. J. Clin. Exp. Pathol. 8(11), 15118\u201315122 (2015)","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"1663_CR33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/dna.2011.1417","volume":"31","author":"C Lang","year":"2012","unstructured":"C. Lang, L. Chen, S. Li, Cytotoxic T-lymphocyte antigen-4\u2009+\u200949G\/A polymorphism and susceptibility to pancreatic cancer. DNA Cell Biol. 31(5), 683\u2013687 (2012). \n                    https:\/\/doi.org\/10.1089\/dna.2011.1417","journal-title":"DNA Cell Biol."},{"issue":"5","key":"1663_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cancergen.2013.04.003","volume":"206","author":"P Gokhale","year":"2013","unstructured":"P. Gokhale, S. Kerkar, H. Tongaonkar, V. Salvi, J. Mania-Pramanik, CTLA-4 gene polymorphism at position\u2009+\u200949 A\u2009>\u2009G in exon 1: a risk factor for cervical cancer in Indian women. Cancer Genet 206(5), 154\u2013161 (2013). \n                    https:\/\/doi.org\/10.1016\/j.cancergen.2013.04.003","journal-title":"Cancer Genet"},{"key":"1663_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4149\/neo_2017_218","volume":"64","author":"N Bilbao-Aldaiturriaga","year":"2017","unstructured":"N. Bilbao-Aldaiturriaga, A. Patino-Garcia, I. Martin-Guerrero, A. Garcia-Orad, Cytotoxic T lymphocyte-associated antigen 4rs231775 polymorphism and osteosarcoma. Neoplasma 64, 299\u2013304 (2017). \n                    https:\/\/doi.org\/10.4149\/neo_2017_218","journal-title":"Neoplasma"},{"issue":"3","key":"1663_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.immuni.2010.09.006","volume":"33","author":"T Yokosuka","year":"2010","unstructured":"T. Yokosuka, W. Kobayashi, M. Takamatsu, K. Sakata-Sogawa, H. Zeng, A. Hashimoto-Tane, H. Yagita, M. Tokunaga, T. Saito, Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 33(3), 326\u2013339 (2010). \n                    https:\/\/doi.org\/10.1016\/j.immuni.2010.09.006","journal-title":"Immunity"},{"issue":"15","key":"1663_CR37","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1158\/0008-5472.CAN-09-0176","volume":"69","author":"T Sun","year":"2009","unstructured":"T. Sun, Z. Hu, H. Shen, D. Lin, Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res. 69(15), 6011\u20136014 (2009). \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0176","journal-title":"Cancer Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1663-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T04:37:19Z","timestamp":1569127039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1663-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1663"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1663-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,4]]},"assertion":[{"value":"21 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}